Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

nari Medical, Inc., a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced positive results from the FLAME study in high-risk/massive pulmonary embolism (“PE”).
News | Pulmonary Embolism
FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever System

March 10, 2023 — Inari Medical, Inc., a medical device company with a mission to treat and transform the lives of ...

Home March 10, 2023
Home
A large UW Medicine-Kaiser Permanente study finds modestly increased risk, with a stronger link seen among younger, healthier people.
News | Atrial Fibrillation
Incident Atrial Fibrillation Appears to Heighten Dementia Risk

March 9, 2023 — People with a recent diagnosis of atrial fibrillation (AF), the most common irregular heart rhythm, have ...

Home March 09, 2023
Home
C. Noel Bairey Merz, MD, Director of the Barbra Streisand Women’s Heart Center at the Smidt Heart Institute, received the distinguished achievement of Master of the ACC (MACC) on March 6 during Annual Scientific Session
News | ACC
American College of Cardiology Honors Women’s Heart Disease Pioneer

March 9, 2023 — C. Noel Bairey Merz, MD, FACC, professor of cardiology and the director of the Barbra Streisand Women’s ...

Home March 09, 2023
Home
Use of an antihypertensive to lower blood pressure in obese patients was found effective, according to Target-HTN Trial results presented during the 2023 American College of Cardiology Scientific Session.
News | ACC
Data from Target-HTN Trial Released at ACC23 Supports Use of Antihypertensive to Reduce Blood Pressure in Obese Patients

March 9, 2023 — Positive results from a Mineralys Therapeutics study, the Target-HTN Phase 2 trial, demonstrated ...

Home March 09, 2023
Home
Study will evaluate THERMOCOOL SMARTTOUCH SF Dual Energy Catheter’s potential to enable safer and simpler procedures with the ability to deliver both radiofrequency and pulsed field ablation
News | Atrial Fibrillation
Biosense Webster’s First Dual Energy Catheter to Treat Atrial Fibrillation Begins Evaluation in SmartfIRE Clinical Trial

March 8, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

Home March 08, 2023
Home
A study to better understand the association between Lipoprotein(a), Lp(a) levels and artherosclerotic cardiovascular disease (ASCVD) in an underrepresented population has been announced by Amgen, which will be working with the Association of Black Cardiologists and the Morehouse School of Medicine on the African American Heart Study.
News | Cardiovascular Clinical Studies
African American Heart Study Announced by Amgen, in Collaboration with Association of Black Cardiologists and Morehouse School of Medicine

March 8, 2023 — A unique community-based partnership, the African American Heart Study, will be conducted to measure the ...

Home March 08, 2023
Home
Wearable sensor could be cheaper, less invasive way to reduce hospital readmissions
News | Wearables
Stick-on Device Provides Early Warning of Heart Failure Complications

March 7, 2023 — People with heart failure were 38% less likely to be readmitted to the hospital for heart failure compli ...

Home March 07, 2023
Home
Partho P. Sengupta, MD, professor of cardiology at Rutgers Robert Wood Johnson Medical School in New Brunswick, New Jersey
News | Wearables
Bracelet Sensor Assesses Troponin Levels to Aid Heart Attack Diagnosis

March 7, 2023 — An experimental wrist-worn device was found to predict troponin-I and obstructed arteries with 90% ...

Home March 07, 2023
Home
Analysis finds most athletes had no cardiac events over seven years, underscoring importance of shared decision-making
News | Implantable Cardioverter Defibrillator (ICD)
Cardiac Risks Appear Low for Elite Athletes with Diagnosed, Treated Genetic Heart Disease

March 7, 2023 — Ninety-five percent of athletes with a diagnosed and treated genetic heart disease experienced no ...

Home March 07, 2023
Home
Kelly Chin, MD, professor of medicine and director of the pulmonary hypertension program at UT Southwestern Medical Center in Dallas
News | Hypertension
Fixed-Dose Combination Pill Outperforms Monotherapy for Pulmonary Hypertension

March 6, 2023 — Patients with pulmonary arterial hypertension (high blood pressure in the arteries that supply the lungs ...

Home March 06, 2023
Home
Neha J. Pagidipati, MD, MPH, associate professor of medicine in cardiology at Duke University School of Medicine and Duke Clinical Research Institute
News | Cardiovascular Clinical Studies
Multifaceted Strategy Boosts Preventive Care for Diabetes, Heart Disease

March 6, 2023 — A multifaceted intervention to improve prescribing practices increased the likelihood that patients with ...

Home March 06, 2023
Home
Atul Verma, MD, head of cardiology at McGill University Health Centre in Montreal, Canada
News | Atrial Fibrillation
New Ablation Technology Found Safe, Effective for Atrial Fibrillation

March 6, 2023 — A new ablation technology known as pulsed field ablation was successful at eliminating episodes of ...

Home March 06, 2023
Home
News | ACC
Findings from STELLAR Phase III Trial Presented at ACC23 Report Novel First-in-class Medication Shows Promise in Treating Rare Heart Lung Condition

March 6, 2023 — In findings presented from the STELLAR Phase III Trial during the American College of Cardiology’s 2023 ...

Home March 06, 2023
Home
Virtual Care Team-Guided Strategy was found to optimize GDMT for hospitalized HF patients according to results of the multi-center IMPLEMENT-HF Trial presented at ACC 23/WCC during a March 6 Featured Clinical Research session.
News | ACC
Virtual Care Team-Guided Strategy Optimizes GDMT for Hospitalized HF Patients in IMPLEMENT-HF Trial, According to Multi-Center Study Presented at ACC 23

March 7, 2023 — A virtual care team-guided strategy for guideline-directed medical therapy (GDMT) optimization was found ...

Home March 06, 2023
Home
Braden Manns, MD, professor of medicine at the University of Calgary
News | Cardiovascular Clinical Studies
Eliminating Copays for Preventive Drugs Does Not Reduce Cardiac Events

March 5, 2023 — Providing medications for chronic diseases—for example, cholesterol-lowering, blood pressure and diabete ...

Home March 05, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now